| Item type |
[ELS]学術雑誌論文 / Journal Article(1) |
| 公開日 |
2017-01-23 |
| タイトル |
|
|
タイトル |
Clinical effect of 3g/day administration of meropenem on severe pneumonia |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Okimoto, Niro
Katoh, Tadashi
Tanaka, Hisataka
Hayashi, Toshikiyo
Kurihara, Takeyuki
Miyashita, Naoyuki
|
| 著者所属(英) |
|
|
|
en |
|
|
Department of General Internal Medicine 1, Kawasaki Hospital, Kawasaki Medical School |
| 著者所属(英) |
|
|
|
en |
|
|
Department of General Internal Medicine 1, Kawasaki Hospital, Kawasaki Medical School |
| 著者所属(英) |
|
|
|
en |
|
|
Department of General Internal Medicine 1, Kawasaki Hospital, Kawasaki Medical School |
| 著者所属(英) |
|
|
|
en |
|
|
Department of General Internal Medicine 1, Kawasaki Hospital, Kawasaki Medical School |
| 著者所属(英) |
|
|
|
en |
|
|
Department of General Internal Medicine 1, Kawasaki Hospital, Kawasaki Medical School |
| 著者所属(英) |
|
|
|
en |
|
|
Department of General Internal Medicine 1, Kawasaki Hospital, Kawasaki Medical School |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
Meropenem |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
3g,day administration |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
Severe pneumonia |
| 記事種別(日) |
|
|
内容記述タイプ |
Other |
|
内容記述 |
症例報告 |
|
言語 |
ja |
| 抄録(英) |
|
|
|
en |
|
|
We examined the clinical effect of Meropenem (MEPM) on severe pneumonia. We administered 3g of Meropenem daily to 20 patients with severe pneumonia: 8 communityacquired pneumonia patients, 9 nursing and healthcare-associated pneumonia patients, and 3 hospital-acquired pneumonia patients. It was effective in 15 of the 20 patients (75%): 8 of 8 community-acquired pneumonia patients (100%), 6 of 9 nursing and healthcare-associated pneumonia patients (66.6%), and 1 of 3 hospital-acquired pneumonia patients (33.3%). Bacteriologically, 9 of a total of 10 strains (90%) were eradicated: 4 of 4 Streptococcus pneumoniae strains, 2 of 2 methicillin-sensitive Staphlococcus aureus strains, 1 of 2 Enterococcus faecalis strains, 1 of 1 Klebsiella pneumoniae strain, and 1 of 1 Escherichia coli strain. Hepatic dysfunction was observed as a side effect in 8 patients (40%). Based on the above, administration of MEPM daily 3 g is extremely effective for community-acquired pneumonia, while it appears ineffective in many cases of nursing and healthcare-associated pneumonia or hospital-acquired pneumonia, and results in hepatic dysfunction at a high frequency. |
| 書誌情報 |
ja : 川崎医学会誌
en : Kawasaki medical journal
巻 39,
号 1,
p. 43-47,
発行日 2013
|
| URL |
|
|
識別子 |
http://igakkai.kms-igakkai.com/wp/wp-content/uploads/2013/KMJ31(1)43-47.2013.pdf |
|
識別子タイプ |
URI |
| DOI |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.11482/2013/KMJ31(1)43-47.2013.pdf |
| ISSN |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0386-5924 |
| ISSN |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2758-089X |
| 雑誌書誌ID |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AN00045593 |
| 雑誌書誌ID |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AN12940574 |
| 著者版フラグ |
|
|
出版タイプ |
VoR |
KJ00008397099.pdf (221.7 kB)
